RE: heads up!27 May 2020 20:01
I have listened to it and feel that his opinion isn’t truly justified. The cash is delivered on performance and only if there is suitable cash flow along with stage payments not all in one go. In regards to CEO ramping I don’t believe that to be the case, he has been pretty quiet it’s only until recently have primer design been more on social media. Obtaining WHO, FDA, NHS, partnership with GSK and AZ, Care Home contract amongst all the other contracts across 100+ Countries hasn’t just come from a guy ramping his flaky business its come from a proven product. What this also does is gives them exposure across all of these other countries for the other revenue streams which aren’t as obviously profitable at Covid 19 at present. If a CEO delivers he should be rewarded not penalised. If he wanted to ramp why are we all here waiting patiently / impatiently for the next RNS. IMO we are well overdue a sales update and there is a reason why. We know the manufacturing arrangements we have and the increase of the test capacity and today’s briefing will only bring more demand with the track and trace. Again IMO AVCT have been ramping with a number of RNSs in a short space of time without having a product to market all in order to increase the MCAP. ODX today another. Why isn’t GM on all the new channels at the moment saying how great their product is, because he’s busy working in the background.